Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FTC 'Ready' To Go After Abusive Citizen Petitions; Allergan Wants 'Substantive' FDA Responses

Dec 05 2018

• By Brenda Sandburg

Vertical stack of multicolor office binders with Statements tags 3D rendering

Related Content

US FDA Amps Up "Name And Shame" Approach To Thwart Anti-Generic Tactics

Oct 03 2018

Shire's Citizen Petitions Too Old For FTC Action; Door Left Open For Amended Suit

Mar 27 2018

FTC’s ‘Awesome’ Suit Against Shire Targets Citizen Petitions

Feb 09 2017

Related Companies

Allergan plc

Takeda Pharmaceutical Co. Ltd.

Additional Topics

United States Generic Drugs Biosimilars Drug Approval Standards FDA Regulation BioPharmaceutical

More from Generics

More from Biosimilars & Generics

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window